Stephen Bardin

Insider Reports History

Location
Berlin, Germany
Signature
/s/ John Dunn, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stephen Bardin:

Company Role Class Num Shares Value Price $ Report Date Ownership
CalciMedica, Inc. Chief Financial Officer Common Stock 40,000 $77,200 $1.93 24 Jun 2025 Direct
CalciMedica, Inc. Chief Financial Officer Common Stock 3,000 $4,507 $1.50 26 Jun 2025 Indirect
ATAI Life Sciences N.V. Chief Financial Officer Stock Option 600,000 14 Mar 2023 Direct
ATAI Life Sciences N.V. Chief Financial Officer Restricted Stock Unit 350,000 14 Mar 2023 Direct
CalciMedica, Inc. Chief Financial Officer Employee Stock Option (Right to Buy) 20,000 24 Jun 2025 Direct

Insider Reports Filed by Stephen Bardin

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CALC CalciMedica, Inc. 24 Jun 2025 2 +$3,005 4 Chief Financial Officer 26 Jun 2025, 18:30
CALC CalciMedica, Inc. 30 May 2025 1 +$1,690 4 Chief Financial Officer 03 Jun 2025, 17:10
CALC CalciMedica, Inc. 23 Apr 2025 1 $0 4 Chief Financial Officer 25 Apr 2025, 16:35
CALC CalciMedica, Inc. 13 Nov 2024 0 $0 3 Chief Financial Officer 15 Nov 2024, 16:04
ATAI ATAI Life Sciences N.V. 14 Mar 2023 2 $0 4 Chief Financial Officer 16 Mar 2023, 20:23
ATAI ATAI Life Sciences N.V. 16 Aug 2022 0 $0 3 Chief Financial Officer 17 Aug 2022, 06:05